FDA Approved: ALENDRONATE SODIUM — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approves the original application for alendronate sodium from Aurobindo Pharma Limited as a generic therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glucocorticoid-induced Osteoporosis
• Osteoporosis
• Paget Disease of Bone
• Postmenopausal Osteoporosis

Drugs mentioned

• ALENDRONATE SODIUM (ALENDRONATE SODIUM)

Snippet

ORIG AP for ALENDRONATE SODIUM (ALENDRONATE SODIUM)